Scott Beach

Scott Beach, a faculty member at the Psychopharmacology Institute, dives into the intriguing findings from the UK Biobank study. He reveals how vitamin D deficiency might elevate dementia risk by up to 25%. The discussion emphasizes the importance of monitoring vitamin D levels, especially in older adults, and suggests that this affordable supplement could be key in bolstering brain health. Beach also highlights the notable differences linked to skin color and gene type, making a compelling case for dietary interventions to promote cognitive well-being.

Scott Beach, an expert in psychopharmacology, shares groundbreaking research on famotidine, a common heartburn medication, and its potential to treat post-COVID brain fog. The discussion highlights the cognitive challenges faced by recovering patients and how this unlikely candidate could alleviate mental haziness. Beach dives into the mechanisms behind famotidine’s effects and presents compelling evidence from clinical assessments. The conversation underscores the urgent need for effective treatments for those grappling with lingering cognitive impairment.

Scott Beach, a psychopharmacology expert, shares insights from a groundbreaking Danish registry study on long-term benzodiazepine use. The findings challenge the belief that patients inevitably escalate dosages over time, revealing that many users decrease their doses instead. Beach discusses the implications for vulnerable populations, particularly in palliative care, where deprescribing is critical. He advocates for a patient-centric approach to treatment, emphasizing the need for personalized prescribing practices and ongoing education to reshape current guidelines.